High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of <i>BRCA1/2</i> Pathogenic Variants: Prevalence and Clinical FactorsIris A.S. Stroot, Denise J. Stommel-Jenner, Marise M. Wagner et al.|Journal of Clinical Oncology|2023Cited by 14
High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in <i>BRCA1/2</i> germline pathogenic variant carriersIris A.S. Stroot, Joost Bart, Harry Hollema et al.|JNCI Journal of the National Cancer Institute|2024Cited by 5
Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriersIris A.S. Stroot, Marian J E Mourits, Joost Bart et al.|Gynecologic Oncology|2024Cited by 2